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doi:10.1016/j.ejvs.2009.11.032Abstract Objectives: The treatment paradigm for patients with critical limb ischaemia (CLI)
has changed over the past decade with an increase in endovascular interventions. Accompa-
nying this shift has been a fundamental question as to whether open surgery or endovascular
therapy represents the optimal treatment for CLI.
Design: Review.
Methods: A review of open versus endovascular surgery was performed. The supporting argu-
ments by respective clinicians of both an ‘open first’ and an ‘endo first’ approach are sum-
marised, followed by the available evidence in the literature for each. A summary of an
informal survey of endovascular surgeons regarding five indications for an ‘open first’ approach
to CLI are reviewed. Present and future clinical tools and research for providing a more objec-
tive decision for intervention in CLI are then summarised.
Results: Supporters of either an ‘open first’ or ‘endo first’ approach make claims which are not
entirely supported by the current level 1 evidence. Five conditions which endovascular surgeons
agree that patients with CLI should be treated primarily by open revascularisation include
common femoral artery pathology; arterial occlusions caused by extrinsic compression patho-
logies; extensive foot gangrene/sepsis; young patients and those requiring dependent-free soft
tissue reconstructions where durability is paramount; and infrageniculate popliteal and proximal
tibial occlusion with single, distal tibial target vessel. Clinical scoring systems and mathematical
modelling of lower extremity disease assist in making a prospective intervention decision.
Conclusion: The treatment of CLI has changed and continued clinical and research work is
focussed on which intervention is more effective. While more attempts at endovascular treat-
ment are made, there remain specific indications for open surgical treatment of CLI. As more
work is done towards determining optimal intervention choices on a patient-specific basis,
clearer indications for either intervention will emerge.
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In the past 10 years, there has been a dramatic increase in
the total number of procedures for critical limb ischaemia
(CLI), with most of that increase occurring in those patients
undergoing endovascular procedures.1 Meanwhile, the
number of open surgical procedures has been reported
either to have remained stable or diminished over the same
time frame. Throughout this paradigm shift in the treatment
of CLI, the indications for the initial application of either
endovascular or open revascularisation remain controversial.
To provide some governing principles, the Trans-Atlantic
Intersociety Consensus (TASC) II consensus document
applied clinical results to identify the location and types of
lower extremity lesions best treated by endovascular or
open approaches.2 These recommendations, however, only
provided strong evidence for those patients with either the
mildest or most severe disease patterns. Most patients ‘in
between’ were still left to the physician’s preference. The
lower morbidity and lack of contraindications to endovas-
cular interventions left many vascular specialists and
institutions advocating an initial endovascular approach for
all patients.
Now, nearly a decade since the shift from open surgery
to endovascular treatment of CLI, there remains contro-
versy regarding the optimal treatment approach to this
disease process. While CLI is the subject of numerous
opinions and lectures, level 1 evidence supporting either
approach is lacking.3 In this review, the current arguments
for both ‘open first’ and ‘endo first’ approaches to CLI are
summarised, followed by the most current published
evidence supporting each approach. Specific parameters
for ‘open first’ approaches to CLI, obtained from informal
surveys of endovascular surgeons who routinely practice
‘endo first’ treatments, are summarised. In conclusion,
current and future work directed at objectively deter-
mining the best first-line treatment for CLI is reviewed.
Arguments for ‘open first’ revascularisation
approach
Those who argue for an ‘open first’ approach emphasise the
durability of the approach, shorter healing times for tissue
loss and similar morbidity to endovascular therapy when
‘minimally invasive’ open approaches are used. Open
procedures, specifically autogenous vein bypasses, have
been observed to have higher patency than endovascular
procedures at similar time points. The application of mini-
mally invasive techniques, such as endoscopic vein harvest
and minimal incision in situ bypasses, may modify open
procedures so that they are no more invasive than endo-
vascular procedures. While many emphasise that there is
a more complete revascularisation with open surgery and
a greater increase in total blood flow, this premise must be
confirmed by more objective evidence and must be the
subject of further investigation. The financial impact of
more durable open procedures over repeated endovascular
procedures upon the health-care system and the relative
economic benefit to the treating physician of multiple
endovascular procedures have not been reported or calcu-
lated. The overall impact to the cost of health care,however, has identified the dramatic increase in the number
of procedures in patients with CLI as one of the causes of
increases in health-care costs over the past decade.Arguments for ‘endo first’ revascularisation
approach
Those who argue for an ‘endo first’ approach make the
point that there is better patient acceptance, a lower
initial morbidity and mortality, fewer wound complications
and a more rapid return to normal activities. The percep-
tion of ‘open first’ surgeons that endovascular procedures
may not provide the same volume of pulsatile flow as open
procedures is offset by the observation that there may not
be as much blood flow increase with endovascular proce-
dures, but it is often adequate to treat most CLI symptoms
despite a shorter patency of intervention. Many of the
patients offered an ‘endo first’ approach have previously
had harvesting of optimal conduits, including saphenous
vein and radial arteries, for cardiac or other procedures and
therefore have inferior open options. In addition, often not
mentioned, is the better reimbursement for endovascular
procedures per hour worked than for open surgery.
The ‘endo first’ approach is also often based on the
limited life expectancy of many of these patients, who have
co-morbidities such as diabetes or renal failure. The
decreased patency of interventions superimposed upon
a severely decreased life expectancy underlies the belief
that there is no adverse consequence to an ‘endo first’
approach in all patients. Furthermore, they propose the
position that an endovascular approach still allows for open
surgery for those who fail percutaneous intervention and
that the subsequent open procedure will not be modified by
preceding endovascular attempts.
Evidence for ‘open first’ revascularisation
approach
There are very few prospective, randomised controlled trials
(RCTs) that directly compare endovascular procedures to
open procedures in comparable patients with comparable
disease locations. The primary study that carried out this
comparison for infrainguinal disease was the Bypass versus
Angioplasty for Severe Ischaemia of the Leg (BASIL) trial.4
The study examined the primary outcome of amputation-
free survival and secondary outcomes including mortality,
morbidity, re-intervention, quality-of-life and cost. In
support of an ‘open first’ approach, the subgroup analysis in
the study found that surgery was the best option for patients
with acceptable surgical risk and adequate vein conduit
available. Those patients treated with open surgery who
were living for 2 years or more after their intervention had
a significantly lower risk of amputation, death or both
combined. There is also unpublished data from Neville et al.
which examined parameters of wound healing, time to
complete wound healing and percentage of complete wound
healing following open and endovascular interventions. They
found that open surgery resulted in a significantly higher
degree of complete wound healing with a trend towards
shorter time to heal when compared with endovascular
Figure 1 Common femoral artery disease represents a loca-
tion agreed to be optimally treated with open revascularization
due to the ease of accessibility, as well as external compression
from the inguinal ligament resulting in failure of endovascular
prostheses. Here progression of common femoral artery disease
on the right, donor leg is threatening this femoral-femoral
bypass.
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open infrainguinal surgical revascularisation. Data extrapo-
lated from the PREVENT III trial considering the effect of
pre-treatment of vein grafts on intimal hyperplasia revealed
1-year primary patency, primary assisted patency and
secondary patency of 60.5%, 76.7% and 80.1%, respectively.5
While there are no corollary, prospectively designed
studies considering patency of infrapopliteal endovascular
interventions, a study of 176 consecutive infrainguinal
endovascular interventions for CLI revealed a 1-year primary
patency rate of 53%.6
Evidence for ‘endo first’ revascularisation
approach
The previously mentioned BASIL trial provided significant
evidence interpreted as favourable to support an ‘endo first’
approach. They found no difference in the primary outcome
of amputation-free survival between open and endovas-
cular-first treatments. Open surgery was associated with
a significantly higher morbidity in the form of wound infec-
tions and myocardial infarctions, a longer hospitalisation
and a higher initial cost. The higher initial cost of surgery was
equal to endovascular treatment at 3 years resulting from
a higher failure rate (20% endo vs. 3% open) requiring a higher
rate of re-interventions (28% endo vs. 17% open). This study,
however, did not evaluate the effect of these repeated
procedures or outcomes longer than 5 years post-interven-
tion. In spite of these shortcomings, this study suggests that
there is clinical equipoise between an ‘endo first’ approach
and an ‘open first’ approach. An RCT comparing open versus
endovascular treatment of symptomatic iliac disease
showed no difference in patency or limb salvage at 4-year
follow-up.7 While some limitations to this study were noted,
a relatively lower morbidity and mortality rate for endo-
vascular intervention supports an ‘endo first’ approach for
this disease location.
Parameters for ‘open first’ revascularisation
approach
In 2009, at the Society for Vascular Surgery annual meeting,
this clinical equipoise was addressed in the form of
a debate, conducted by two vascular surgeons who had
access to and training in both endovascular and open
techniques. Each was a strong advocate for either an initial
endovascular or open approach to treating CLI. At the
conclusion of the debate, over 700 vascular specialists who
were present were asked to vote on the evidence presented
during the debate and whether they favoured an open or
endovascular initial approach as initial therapy of infrain-
guinal arterial occlusive disease of TASC D complexity. The
audience overwhelmingly voted in support of the open
approach, while concurrently reporting more frequently
using an endovascular approach in their practices. Why did
they believe that the evidence supported an initial open
approach and yet use an endovascular approach for their
patients with TASC D disease? Was it the professional
reimbursement that favours the endovascular approach, or
was it that these lesions are much less common than TASC
A, B or C lesions in their practices?To answer questions about the motivation and practice
of using the ‘open first’ approach in selected patients with
TASC D disease, we interviewed several committed endo-
vascular surgeons and asked them the following question:
As an ‘endo first’ vascular surgeon, what are the situations
in which you would favour an ‘‘open first’’ approach? These
surgeons came up with five situations in which an open
approach should be the initial therapy, despite their
common application of initial endovascular treatment.
1. Anatomy: These vascular surgeons felt that certain
pathology, when located in specific anatomic locations,
made the open approach more attractive. This included
patients with disease primarily of the common femoral
artery (Fig. 1). In common femoral artery disease, the
atherosclerosis often extends above the inguinal liga-
ment and is difficult to treat with endovascular proce-
dures. Commonly, the calibre of the femoral is larger
than most atherectomy devices, the plaque burden is
great and the vessel is often calcified, making it partic-
ularly challenging for endovascular procedures. In
addition, the surgical procedure is relatively low risk and
simple, with a small subcutaneous incision and a rapid
recovery.
2. Pathology: Certain disease of the infrapopliteal vessels
is not conducive to angioplasty/stenting and includes
extrinsic compression from popliteal entrapment,
adventitial cystic disease and exostoses associated with
arterial compression and occlusion (Fig. 2). In each of
these circumstances, an dendovascular procedure does
not eliminate the cause of the stenosis, and when there
is extrinsic compression, the underlying cause of the
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endovascular procedure.
3. Physiology: When patients have extensive foot sepsis or
gangrene, open procedures deliver more pulsatile flow
to the limb, and therefore should be used in these
clinical settings (Fig. 3). Until a system is devised to
determine the volume of blood flow needed to resolve
particular clinical problems, the maximum blood flow
should be delivered in settings where there is a high risk
of limb loss without a marked increase in blood flow.
This clinical scenario is particularly relevant to
emergency situations with extensive foot gangrene
and/or infection. Endovascular approaches run the risk
of providing increased but inadequate flow to the foot,
which is not discovered to be inadequate until more
tissue is lost, often mandating a higher level of
amputation.
4. Durability: Patients who are young and need limb-
salvage procedures for critical limb ischaemia require
a durable procedure. Endovascular procedures have
considerably shorter durability in most situations and
therefore need repeated procedures for restenosis. In
addition, some patients need a long-term durable
procedure for maintenance of a free flap or a distal
procedure that is dependent on the patency of the
proximal procedure (Fig. 4). In this case, an open
procedure is preferable. Endovascular procedures in
young patients may relegate the patient to repeated,
lifelong procedures with repeated hospitalisations,
thrombolysis and eventual failure of the revascularisa-
tion procedure.
5. Limited distal targets: Occlusion of the infrageniculate
popliteal artery as well as the origins of all three tibialFigure 2 Open surgical treatment of certain pathologies, such as
from the femur shown here, appears to be preferred over endov
entrapment and adventitial cystic disease.arteries presents a challenging endovascular revascu-
larisation primarily due to limited patency and high
failure rates (Fig. 5). Every vascular surgeon has
encountered a situation where a patient with an
excellent conduit and a single distal target vessel in the
ankle or foot loses that target during repeated endo-
vascular procedures, due to embolism or thrombosis of
the target vessel. When a patient has a good conduit
and a good, but single target, this is an optimal situa-
tion for an open procedure before that target is lost.Current and future approaches to treatment
choice
While most dialogue regarding the choice between open
and endovascular treatments of CLI has been based on the
evidence produced from clinical trials and series, the
logical solution would involve the creation of a prospective
tool to determine which intervention would result in the
greatest benefit. Taylor et al. proposed a scoring system,
known as the Lower Extremity Grading System (LEGS)
score, to guide initial treatment of those with CLI.8 This
system incorporates several clinical variables such as
disease location, symptoms, functional status, co-morbid-
ities and technical factors to arrive at a composite index
which directs treatment to either open surgery, endovas-
cular treatment or primary amputation. They found that
the application of this scoring system predicted the actual
or offered clinical treatment 90% of the time. In a more
engineering-based approach to objective decision making
regarding optimal intervention, the authors of this article
proposed and presented the concept of mathematicalocclusion of the superficial femoral artery from bony exostoses
ascular techniques. Other such pathologies include popliteal
Figure 5 Severe occlusive disease involving occlusions of the
infrageniculate popliteal artery and the proximal segments of
the tibial arteries pose a technical challenge for endovascular
recanalization. With patients who have single distal targets
and CLI, an autogenous vein distal bypass often provides the
more durable reconstruction. These patients, with percuta-
neous revascularization, are often at risk for embolic/throm-
botic occlusion of the reconstituted distal tibial artery.
Figure 3 Severe limb gangrene and/or sepsis involving the
forefoot (left) or the lower leg (right) is more often treated with
open surgical revascularization than endovascular therapy.
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ventions as a method of preoperatively predicting whether
open bypass or angioplasty/stent would result in a higher
distal perfusion pressure.9 With work towards expanding
this model to include the entire lower extremity circula-
tion, multi-level disease could be modelled along with
several intervention options including open, endovascular
or a combination of both. Further work must be done as
well trying to quantify the actual changes in tissue perfu-
sion and distal blood flow after either open or endovascular
treatment and compare the two. In a field as studied as
this, it seems peculiar that concepts such as quantifiable
patterns of tissue perfusion after certain anatomic revas-
cularisations and measurable levels of tissue blood perfu-
sion needed to heal wounds or ameliorate rest pain remain
unknown. Clearly, this information would assist in clarifying
the debate.Figure 4 Due to improved patency associated with autoge-
nous vein bypasses, these are often the optimal choice over
endovascular techniques for patients requiring free-tissue
coverage. These flaps have greater viability when their blood
flow is dependant on native circulation or an autogenous
conduit.Conclusion
In conclusion, CLI has been treated primarily with open
surgical bypass prior to the increase of endovascular
treatment nearly 1 decade ago. The debate continues
regarding the optimal initial intervention with practitioners
applying either an ‘open first’ or ‘endo first’ strategy. There
are specific arguments lavied by each side supporting their
approach. While copious retrospective, observational clin-
ical data exist examining this topic, there are very few
prospective RCTs supporting either approach exclusively. A
survey of endovascular surgeons with a preference for an
‘endo first’ approach revealed five parameters which would
guide them to apply open surgery as the initial treatment
for CLI. To further guide decision making, prospective tools
have been developed and are the basis of further research
work. Once the ability to quantify limb perfusion in the
setting of CLI is available, more information regarding the
effectiveness of open versus endovascular treatment will
be realised and a refined approach to the treatment of CLI
can be constructed.
Conflict of Interest/Funding
None.References
1 Kudo T, Chandra FA, Kwun W, Haas BT, Ahn SS. Changing pattern
of surgical revascularization for critical limb ischemia over 12
Open vs Endovascular Surgery for CLI S37years: endovascular vs. open bypass surgery. J Vasc Surg 2006;
44:304e13.
2 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FGTASC II Working Group. Inter-society consensus for the
management of peripheral arterial disease (TASC II). J Vasc Surg
2007;45(Suppl.):S5eS67.
3 Beard JD. Which is the best revascularization for critical limb
ischemia: endovascular or open surgery? J Vasc Surg 2008;48:
11Se16S.
4 Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF,
et al. Bypass versus angioplasty in severe ischaemia of the leg
(BASIL): multicentre, randomized controlled trial. Lancet 2005;
366:1925e34.
5 Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF,
Clowes AW, et al. Technical factors affecting autogenous vein
graft failure: observations from a large, multicenter trial. J Vasc
Surg 2007;46(6):1180e90.6 Giles KA, Pomposelli FB, Hamdan AD, Blattman SB,
Panossian H, Schermerhorn ML. Infrapopliteal angioplasty for
critical limb ischemia: relation of Trans-Atlantic Intersociety
Consensus class to outcome in 176 limbs. J Vasc Surg
2008;48(1):128e36.
7 Wolf GF, Wilson SE, Cross AP, Deupree RH, Stason WB. Surgery
or balloon angioplasty for peripheral vascular disease;
a randomized clinical trial. J Vasc Interv Radiol 1993;4:
639e48.
8 Taylor S, Kalbaugh CA, Gray BH, Mackrell PJ, Langan EM, Cull DL,
et al. The LEGS score: a proposed grading system to direct
treatment of chronic lower extremity ischemia. Ann Surg 2003;
237(6):812e9.
9 Chandra A, Lawrence PF. Mathematical modeling of the femoral
artery and its application to predict the outcome of arterial
interventions [Abstract]. Arterioscler Thromb Vasc Biol 2009;
29(7):e54ee55.
